ISSN: 2161-1025
Department of Pharmaceutical Sciences, Mercer University, Georgia, United States
Research Article
Evaluation of Microparticulate Cytokine Inhibitors for their Potential Use for the Treatment of COVID-19 Cytokine Storm
Author(s): Mohammad N. Uddin*, Priyal Bagwe, Carl Oettinger and Martin J. D'Souza
COVID-19 pandemic has claimed millions of lives and resulted in an economic slowdown worldwide. The mortality rate is approximately 2% in the United States, with many individuals requiring prolonged hospitalization. At least 10% of patients with severe COVID-19 will eventually have respiratory failure. The recent deployment of a vaccine will hopefully ease and ultimately deter the spread of this highly contagious virus. However, newer virulent strains continue to emerge since most people in different parts of the world have little or no access to vaccines. The virus is associated with the cytokine storm in its severe form. This manifestation is highly lethal, resulting in acute respiratory distress syndrome and multi-organ failure. Since only a few therapeutic drugs can treat severe COVID-19, it is essential to focus on therapeutic strategies to increase the COVID-19 survi.. View More»
DOI:
10.35248/2161- 1025.22.12.258